Trial Profile
A trial to investigate the anti-cancer efficacy of VB6-901
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 18 Jun 2015
Price :
$35
*
At a glance
- Drugs VB 6901 (Primary)
- Indications Cancer
- Focus Therapeutic Use
- 18 Jun 2015 New trial record